Results 91 to 100 of about 13,836,890 (356)

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

REPORT ON PROGRESS OF TRENCH FEVER INVESTIGATIONS [PDF]

open access: green, 1918
Richard P. Strong   +5 more
openalex   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Report on Progress in Obstetrics [PDF]

open access: yesThe Boston Medical and Surgical Journal, 1892
n ...
openaire   +3 more sources

Report of Progress in the Investigation of Rivers [PDF]

open access: green, 1908
A. Strahan   +3 more
openalex   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

Report on Progress of Ophthalmology [PDF]

open access: yesThe Boston Medical and Surgical Journal, 1881
n ...
openaire   +3 more sources

A progress report… bee pollination in cucumbers for pickling

open access: yesCalifornia Agriculture, 1969
Selective admission of bees to cucumber blossoms (through use of a field screening procedure) resulted in production of fruit yields roughly proportional to the length of time the bees were admitted and to the field activity level of bees during that ...
W Seyman   +4 more
doaj  

Home - About - Disclaimer - Privacy